Preterm labour: Recent advances in understanding of pathophysiology, diagnosis and management

Current Opinion in Obstetrics and Gynecology

Volumn 10, Issue 2, 1998, Pages 151-156

  Booking, Alan D ^a  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; ALPHA FETOPROTEIN; ANTIBIOTIC AGENT; ATOSIBAN; BETAMETHASONE; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; FIBRONECTIN; GLUCOCORTICOID; GLYCERYL TRINITRATE; MAGNESIUM SULFATE; NITRIC OXIDE DONOR; RITODRINE; UTERUS SPASMOLYTIC AGENT;

ANTIBIOTIC THERAPY; FEMALE; HUMAN; INCIDENCE; INFECTION; PATHOPHYSIOLOGY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW;

FEMALE; GLUCOCORTICOIDS; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TOCOLYTIC AGENTS;

EID: 0031946305     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199804000-00012     Document Type: Review

References (60)

1. Wildschut Hajo IJ, Nas T, Golding J. Are sociodemographic factors predictive of preterm birth? A reappraisal of the 1958 British Perinatal Mortality Survey. Br J Obstet Gynaecol 1997; 104:57-63. A reassessment of the data obtained from all births in England, Scotland and Wales during the first week of March 1958 has revealed that, at that time, sociodemographic factors did not have a substantial impact on the risk of preterm birth.
2. Schieve LA, Handler A. Preterm delivery and perinatal death among black and white infants in a Chicago-area perinatal registry. Obstet Gynecol 1996; 88:356-363.
3. Cooperstock M, Campbell J. Excess males in preterm birth: interactions with gestational age, race, and multiple birth. Obstet Gynecol 1996; 88:189-193.
4. Wisborg K, Henriksen TB, Hedegaard M, Secher NJ. Smoking during pregnancy and preterm birth. Br J Obstet Gynaecol 1996; 103:800-805.
5. Hickey CA, Cliver SP, McNeal SF, Goldenberg RL. Low pregravid body mass index as a risk factor in preterm birth: variation by ethnic group. Obstet Gynecol 1997; 89:206-212.
6. Copper RL, Goldenberg RL, Das A, Elder N, Swain M, Norman G, et al. The Preterm Prediction Study: Maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation. Am J Obstet Gynecol 1996; 175:1286-1292. A prospective study assessing anxiety, stress, self-esteem, mastery and depression in pregnant women at 25-29 weeks' gestation has shown a significant association between maternal stress and preterm birth, even after adjustment for maternal demographic and behavioural characteristics.
7. Korebrits C, Ramirez MR, Bocking AD, Challis JRG. Evaluation of endocrine discriminators of true and false preterm labour in patients at 24-37 weeks of pregnancy [abstract 121]. J Soc Gynecol Invest 1997; 4:109A.
8. Korebnts C, Yu D, Ramirez M, Marinoni E, Bocking A, Challis J. Gestation dependent effects of prenatal glucocorticoid administration on corticotropin releasing hormone (CRH) in maternal plasma [abstract 647]. J Soc Gynecol Invest 1997; 4:242A.
9. Henriksen TB, Baird DD, Olsen J, Hadegaard M, Secher NJ, Wilcox AJ. Time to pregnancy and preterm delivery. Obstet Gynecol 1997; 89:594-599.
10. van Meir CA, Matthews SG, Keirse MJNC, Ramirez MM, Bocking A, Challis JRG. 15-Hydroxy-prostaglandin dehydrogenase (PGDH): implications in preterm labor with and without ascending infection. J Clin Endocrinol Metab 1997; 82:969-976.
11. Steinborn A, Günes H, Räddiger S, Halberstadt E. Elevated placental cytokine release, a process associated with preterm labor in the absence of intrauterine infection. Obstet Gynecol 1996; 88:534-539.
12. Ali KZM, Ali ME, Khalid MEM. High altitude and spontaneous preterm birth. Int J Gynecol Obstet 1996; 54:11-15.
13. Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obsfet Gynecol 1996; 88:816-822.
14. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997; 177:13-18.
15. Malak TM, Sizmur F, Bell SC, Taylor DJ. Fetal fibronectin in cervicovaginal sections as a predictor of preterm birth. Br J Obstet Gynaecol 1996; 103:648-653.
16. Lukes AS, Thorp JM, Eucker B, Pahel-Short L. Predictors of positivity for fetal fibronectin in patients with symptoms of preterm labor. Am J Obstet Gynecol 1997; 176:639-641.
17. Rizzo G, Capponi A, Arduini D, Lorido C, Romanini C. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996; 175:1146-1151.
18. Rozenberg P, Goffinet F, Malagrida L, Giudicelli Y, Perdu M, Houssin I, et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1997; 176:196-199.
19. Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Meis PJ, Das A, et al. The Preterm Prediction Study: Patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. Am J Obstet Gynecol 1997; 177:8-12.
20. Greenhagen JB, Van Wagoner J, Dudley D, Hunter C, Mitchell M, Logsdon V, et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol 1996; 175:1054-1056.
21. Bittar RE, Yamasaki AA, Sasaki S, Zugaib M. Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996; 175:178-181.
22. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, et al. The preterm prediction study, risk factors in twin gestations. Am J Obstet Gynecol 1996; 175:1047-1053.
23. Zygmunt M, Lang U, Katz N, Künzel W. Maternal plasma fibronectin: a predictor of preterm delivery. Eur J Obstet Gynecol Reprod Biol 1997: 72:121-126.
24. Gibbs RS, Eschenbach DA. Use of antibiotics to prevent preterm birth. Am J Obstet Gynecol 1997; 177:375-380. This review identifies the rationale for treating women with specific genital tract infections during pregnancy.
25. Egarter C, Leitich H, Husslein P, Kaider A, Schemper M. Adjunctive antibiotic treatment in preterm labor and neonatal morbidity: a meta-analysis. Obstet Gynecol 1996; 88:303-309. A meta-analysis of seven trials has revealed that adjunctive antibiotic therapy in women with preterm labour and intact membranes does not reduce the rate of neonatal morbidity.
26. Holleboom CAG, Merkus JMWM, van Elferen LWM, Keirse MJNC. Randomized comparison between a loading and incremental dose model for ritodrine administration in preterm labour. Br J Obstet Gynaecol 1996; 103:695-701.
27. Holleboom CAG, Merkus JMWM, van Elferen LWM, Keirse MJNC. Double-blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labour. Br J Obstet Gynaecol 1996; 103:702-705.
28. Zalar RW. Transvaginal ultrasound and preterm prelabor: a nonrandomized intervention study. Obstef Gynecol 1996; 88:20-23.
29. Goodwin TM, Valenzuela GJ, Silver H, Creasy G. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Obstet Gynecol 1996; 8:331-336.
30. Rowlands S, Trudinger B, Visva-Lingam S. Treatment of preterm cervical dilatation with glyceryl trinitrate. a nitric oxide donor. Aust NZ J Obstet Gynaecol 1996; 36:377-381.
31. Jones GD, Poston L. The role of endogenous nitric oxide synthesis in contractility of term or preterm human myometrium. Br J Obstet Gynaecol 1997; 104:241-245.
32. Piper JM, Atkinson MW, Mitchel EF, Cliver SP, Snowden M, Wilson SC. Improved outcomes for very low birth weight infants associated with the use of combined maternal corticosteroids and tocolytics. J Reprod Med 41:692-698.
33. Yeshaya A, Orvieto R, Ben-Shem E, Dekel A, Peleg D, Dicker D, Ben-Rafael Z. Uterine activity after betamethasone administration for the enhancement of fetal lung maturation. Eur J Obstet Gynecol Reprod Biol 1996; 67:139-141.
34. Egerman RS, Pierce WF, Andersen RN, Umstot ES, Carr TL, Sibai B. A comparison of the bioavailability of oral and intramuscular dexamethasone in women in late pregnancy. Obstet Gynecol 1996; 89:276-280.
35. Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 1996; 276:1805-1810. A cohort study of over 1000 very low birthweight infants delivered in Georgia, USA, between 1986 and 1988 has revealed a reduced risk of cerebral palsy and possibly mental retardation in children exposed to magnesium sulfate in utero.
36. Nelson KB. Magnesium sulfate and risk of cerebral palsy in very low-birth weight infants. JAMA 1996; 276:1843-1844.
37. Corwin MJ, Mou SM, Sunderji SG, Gall S. How H, Patel V, Gray M. Multicenter randomized clinical trial of home uterine activity monitoring: pregnancy outcomes for all women randomized. Am J Obstet Gynecol 1996; 175:1281-1285.
38. CHUMS Group, comprising Davoe LD, Artal R, Weiner C, Witter F, McGregor J, Harrigan J, et al. A multi-center randomized controlled trial of home uterine monitoring: active versus sham device. Am J Obstet Gynecol 1995; 173:1120-1127.
39. French Jl, McGregor JA. The pathobiology of premature rupture of membranes. Semin Perinatol 1996; 20:344-368. This article reviews the current state of knowledge regarding the structure and function of fetal membranes and mechanisms, including infection-related causes, whereby the integrity of the membranes may be disrupted.
40. Bendon RW. Histopathology of fetal membrane rupture: a review of the literature. Semin Perinatol 1996; 20:381-388.
41. Anai T, Tanaka Y, Hirota Y, Miyakawa I. Vaginal fluid hCG levels for detecting premature rupture of membranes. Obstet Gynecol 1997; 89:261-264.
42. Yoon BH, Jun JK, Park KH, Syn HC, Gomez R, Romero R. Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet Gynecol 1996; 88:1034-1040.
43. Beazley D, Lewis R. The evaluation of infection and pulmonary maturity in women with premature rupture of the membranes. Semin Perinatol 1996; 20:409-417.
44. Carroll SG, Philpott-Howard J, Nicolaides KH. Amniotic fluid Gram stain and leukocyte count in the prediction of intrauterine infection in preterm prelabour amniorrhexis. Fetal Diagn Ther 1996; 11:11-15.
45. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. JAMA 1997; 278:989-995. A randomized, double-blind, placebo-controlled trial has shown that a 48 h course of intravenous ampicillin and erythromycin followed by 5 days of oral amoxicillin and erythromycin in women with preterm premature rupture of the membranes between 24 and 32 weeks of gestation leads to a significant decrease in the incidence of neonatal respiratory distress and necrotizing enterocolitis, as well as prolongation of the pregnancy.
46. Mercer BM, Arheart KL. Antibiotic therapy for preterm premature rupture of the membranes. Semin Perinatol 1996; 20:426-438.
47. Imseis HM, Iams JD. Glucocorticoid use in patients with preterm premature rupture of the fetal membranes. Semin Perinatol 1996; 20:439-450.
48. Lewis DF, Brody K, Edwards MS, Brouillette RM, Burlison S, London SN. Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics. Obstet Gynecol 1996; 88:801-805.
49. Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol1997; 89:265-271. Careful analysis of the placentas of women who give birth after pPROM shows that evidence of histological chorioamnionitis is present in only 43% of cases, with the majority of these being from those women giving birth before 30 weeks' gestation.
50. Alexander JM, Cox SM. Clinical course of premature rupture of the membranes. Semin Perinatal 1996; 20:369-374.
51. Merenstein GB, Weisman LE. Premature rupture of the membranes: neonatal consequences. Semin Perinatol 1996; 20:375-380.
52. Schucker JL, Mercer BM. Midtrimester premature rupture of the membranes. Semin Perinatol 1996; 20:389-400.
53. Hanley ML, Vintzileos AM. Biophysical testing in premature rupture of the membranes. Semin Perinatol 1996; 20:418-425.
54. Tyson JE, Younes N, Verter J, Wright LL. Viability, morbidity, and resource use among newborns of 501 to 800 g birth weight. JAMA 1996; 276:1645-1651.
55. Tin W, Wariyar U, Hey E. Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994. BMJ 1997; 314:107-111. An analysis of perinatal outcomes for all births between 1983 and 1994 at 22 to 27 completed weeks' gestation in the north of England has shown a steady improvement in survival with no significant change in the rate of disability among survivors.
56. Dusick AM, Medical outcomes in preterm infants. Semin Perinatol 1997; 21:164-177.
57. Bennett FC, Scott DT. Long-term perspective on premature infant outcome and contemporary intervention issues. Semin Perinatol 1997; 21:190-201.
58. Vohr BR, Msall ME. Neuropsychological and functional outcomes of very low birth weight infants. Semin Perinatol 1997; 21:202-220.
59. Leonard CH, Piecuch RE. School age outcome in low birth weight preterm infants. Semin Perinatol 1997; 21:240-253.
60. Chapieski ML, Evankovich KD. Behavioural effects of prematurity. Semin Perinatol 1997; 21:221-239.